Description
The GenVoy-ILM T Cell Kit for mRNA, Spark is a lipid nanoparticle mix. It is optimized for the delivery of RNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges.
This kit enables researchers to establish a clinically relevant and scalable method for ex vivo gene delivery to advance the development of T cell therapies. It can be used at various stages of cell therapy research and development from discovery to preclinical across the NxGen™ microfluidics instrument platform.
Features:
Lipid Nanoparticle are Clinically Validated - LNP technology represents the most advanced non-viral RNA delivery technology and has been validated in the clinic for the delivery of siRNA (Onpattro®)
High Cell Viability - Achieve high potency without causing cytotoxicity using this reagent kit, resulting in highly viable cells that can be assayed in vitro and in vivo.
High-efficiency Genome Editing - Deliver mRNA into activated primary T cells consistently with high efficiency.
Tunable Biological Outcomes - Achieve an ideal balance between protein expression and cell viability in a dose-dependent manner.